Good luck to you Jiway, glad it worked for your dog, but how does it go on humans?
You seem to missing the point, the Canine POC results will be low hanging fruit for the company to show that much higher concentrations of CBD can be infiltrated through the skin of dogs and subsequently humans because they are anatomically closely linked.
The line the company is going down is to monetise the BTX1204A with a big pharma who are experts in producing and marketing animal products eg. Pfizer who also have human products. The prized Dermatitis market is the multi billion dollar human market.
If they can get up to 15% of synthetic CBD through the skin in dogs it paves the way to reboot the human trial and have the funds from monetized Canine product to fund it.
There is no hint whatsoever of a capital raising and quite frankly if they did it now they would lose ALL respect but the board are smart enough to monetize a product first before any of those ideas cross the board table.
It is still an exciting cashed up company but Covid has just delayed things.
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix Roadshow Presentation
Ann: Botanix Roadshow Presentation, page-18
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
42.0¢ |
Change
-0.005(1.18%) |
Mkt cap ! $761.8M |
Open | High | Low | Value | Volume |
43.0¢ | 44.5¢ | 41.5¢ | $2.435M | 5.697M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 819538 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 29052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 812389 | 0.415 |
12 | 882907 | 0.410 |
12 | 652220 | 0.405 |
22 | 618050 | 0.400 |
7 | 263887 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 19000 | 2 |
0.430 | 1700 | 1 |
0.435 | 280334 | 3 |
0.440 | 756891 | 12 |
0.445 | 202539 | 8 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online